Zivo Bioscience, Inc. (ZIVO) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 199 transactions totaling $5.6M, demonstrating a bullish sentiment with $5.6M in net insider flow. The most recent transaction on Feb 10, 2026 involved a purchase of 2,434 shares valued at $25.0K.
No significant insider buying has been recorded for ZIVO in the recent period.
No significant insider selling has been recorded for ZIVO in the recent period.
Based on recent SEC filings, insider sentiment for ZIVO is bullish with an Insider Alignment Score of 100/100 and a net flow of $5.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Zivo Bioscience, Inc. (ZIVO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading ZIVO stock, having executed 199 transactions in the past 90 days. The most active insider is Christopher D. Maggiore (Executive), who has made 164 transactions totaling $5.1M.
Get notified when executives and directors at ZIVO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | L. Yaldoo Laith | Executive | Purchase | 2,434 | $10.27 | $25.0K | |
| Jan 26, 2026 | A. Cornell Alison | Executive | Purchase | 11,709 | $8.54 | $100.0K | |
| Jan 14, 2026 | L. Yaldoo Laith | Executive | Purchase | 1,766 | $8.49 | $15.0K | |
| Jan 14, 2026 | D. Maggiore Christopher | Executive | Purchase | 1,766 | $8.49 | $15.0K | |
| Nov 28, 2025 | L. Yaldoo Laith | Executive | Purchase | 2,777 | $9.00 | $25.0K | |
| Oct 13, 2025 | Management Lp Strome Investment | Executive | Purchase | 20,259 | $12.34 | $250.0K | |
| Oct 10, 2025 | L. Yaldoo Laith | Executive | Purchase | 1,659 | $12.05 | $20.0K | |
| Oct 8, 2025 | D. Maggiore Christopher | Executive | Purchase | 23,682 | $12.01 | $284.4K | |
| Sep 30, 2025 | L. Yaldoo Laith | Executive | Purchase | 15,322 | $15.99 | $245.0K | |
| Aug 22, 2024 | D. Maggiore Christopher | Executive | Purchase | 31,336 | $8.34 | $261.3K | |
| Aug 22, 2024 | A. Cornell Alison | Executive | Purchase | 11,990 | $8.34 | $100.0K | |
| Jul 26, 2024 | D. Maggiore Christopher | Executive | Purchase | 2,080 | $8.05 | $16.7K | |
| Jun 12, 2024 | D. Maggiore Christopher | Executive | Purchase | 3,764 | $7.97 | $30.0K | |
| Jun 11, 2024 | E. Masterson Nola | Executive | Award | 6,273 | $N/A | $0 | |
| Jun 11, 2024 | D. Maggiore Christopher | Executive | Award | 6,273 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 178 | $5.6M | 53.4% |
Conversion(C) | 1 | $2.6M | 24.9% |
Award(A) | 10 | $2.1M | 19.8% |
Exercise(M) | 6 | $119.5K | 1.1% |
Payment(F) | 4 | $82.0K | 0.8% |
Insiders at Zivo Bioscience, Inc. are accumulating shares at an accelerated pace. With 9 insiders making 199 transactions totaling $5.6M in purchases versus $0 in sales, the net buying activity of $5.6M signals strong executive confidence. Christopher D. Maggiore (Executive) leads the buying activity with $5.1M in transactions across all time.